# Redhill Capital

> Redhill Capital is a VC fund backing Health Care and Biotechnology. See 33 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Guangzhou, China
- Total investments: 33
- Last investment: Feb 2026
- Lead investor: 58%
- Last fund: Aug 2020
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/redhill-capital-%E4%B8%B9%E9%BA%93%E8%B5%84%E6%9C%AC
- Website: http://redhillcapital.cn

Redhill Capital is a venture capital firm specializing in early stage investment. It primary invests in medical industry.

## Contacts

5 contacts available for Redhill Capital. Shizune tracks 4 team members at Redhill Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/redhill-capital?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 10 | 30% |
| Biotechnology | 8 | 24% |
| Medical | 7 | 21% |
| Biopharma | 4 | 12% |
| Medical Device | 4 | 12% |

30 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 9 | 27% |
| Angel | 6 | 18% |
| Series A | 6 | 18% |
| Venture - Series Unknown | 4 | 12% |
| Series B | 3 | 9% |

7 stages tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Frank Su | Founding Partner | 0 | https://shizune.co/investors/profile/frank-su |
| Cherry Lu | Founding and Managing Partner | 0 | https://shizune.co/investors/profile/cherry-lu |
| Dr. Li Jie | Managing Director | 5 | https://shizune.co/investors/profile/dr-li-jie |
| Lu Qinchao | Redhill Capital is a venture capital firm focusing on the medical industry. | 5 | https://shizune.co/investors/profile/lu-qinchao |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Creatulize | Creatulize is a technology company specializing in the field of intelligent robots. |  | Angel | Feb 11, 2026 |  |
| Xintu Intelligent Sense | Xintu Intelligent Sensor is a design company dedicated to high-performance sensor chips. Focused on intelligent sensing chips and edge-to-edge intelligent products integrating multi-dimensional sensing and AI. |  | Series A | Aug 06, 2025 |  |
| Guangna Development | Guangna Siwei is an optoelectronic device seller. |  | Seed | Mar 03, 2025 |  |
| Inflamax Pharmaceuticals | Inflamax Pharmaceuticals is a biomedical technology company that specializes in the innovation and development of immune-inflammatory drugs. |  | Angel | Oct 20, 2023 |  |
| Douli | Douli is an employee service platform that provides welfare solutions for enterprises. They offer services in the fields of clothing, food, housing, transportation, medical care, entertainment, and more by combining online and offline multi-channel resources. |  | Venture - Series Unknown | Aug 08, 2023 |  |
| EnCureGen Pharmaceuticals | Huizhengqi Medicine is a pharmaceutical company that develops mRNA drugs for the treatment of tumor and immunity diseases. |  | Seed | Jun 08, 2023 |  |
| Xianwei Medical | Xianwei Medical is a manufacturer of ophthalmic surgical robots. It focuses on the field of ophthalmic surgical robots, promoting the product finalization and inspection of the third-generation ophthalmic surgical robots while also starting the medical treatment of other product pipelines under research, such as dry eye treatment equipment. |  | Angel | May 17, 2023 |  |
| ZD Medtech | Zhuo Dao Medical has a domestic R&D team of rehabilitation robots dedicated to providing world-leading robotic assistive technology and intelligent rehabilitation solutions for clinical rehabilitation. With rich training mode, excellent human-computer interaction and intelligent rehabilitation management system, Zhuo Dao Medical is adapting tothe needs of Chinese rehabilitation medicine through continuous accumulation and continuous innovation in the field of rehabilitation engineering, and promoting the rapid development of rehabilitation medicine. . | $14.6M | Series B | Feb 15, 2023 |  |
| ExoNeuglia | ExoNeuglia is a biotech company that specializes in the development of cell drugs through the induced reprogramming pathway and therapies for nervous system diseases. |  | Seed | Dec 08, 2022 |  |
| Huawei Hengyuan | Huawei Hengyuan is a biomedical technology company dedicated to the preparation of Sertoli cells (with immune immunity) in vitro using cell reprogramming technology, mainly for: autoimmune diseases (such as rheumatoid arthritis); reproductive adjuvant therapy; human body Chronic diseases (such as Parkinson's); organ/tissue colonization(such as skin allograft). |  | Seed | Dec 05, 2022 |  |

10 of 33 investments shown.

## Co-investors
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund, 4 deals together
- [Airport Ventures](https://shizune.co/investors/profile/airport-ventures) — VC Fund, 2 deals together
- [Shunwei Capital](https://shizune.co/investors/profile/shunwei-china-internet-fund) — VC Fund, 2 deals together
- [Sinopharm Capital](https://shizune.co/investors/profile/sinopharm-capital) — VC Fund, 2 deals together
- [Alwin Capital](https://shizune.co/investors/profile/alwin-capital) — VC Fund, 1 deal together
- [Ambrum Capital](https://shizune.co/investors/profile/ambrum-capital) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [HSG](https://shizune.co/investors/profile/sequoia-capital-china) — VC Fund

## Featured in investor lists
- [Health Care Investors in China](https://shizune.co/investors/health-care-investors-china)
- [Health Care VC Funds in China](https://shizune.co/investors/health-care-vc-funds-china)
- [Biotechnology Investors in Asia](https://shizune.co/investors/biotechnology-investors-asia)
- [Biotechnology Investors in China](https://shizune.co/investors/biotechnology-investors-china)
- [Biotechnology VC Funds in China](https://shizune.co/investors/biotechnology-vc-funds-china)
- [Biotech Investors in Asia](https://shizune.co/investors/biotech-investors-asia)

## FAQ

### What does Redhill Capital invest in?

Redhill Capital invests primarily in Health Care, Biotechnology and Medical startups, most often at Seed and Angel stage. Most of the 33 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Redhill Capital?

Public channels for Redhill Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Redhill Capital?

The team at Redhill Capital includes Frank Su (Founding Partner), Cherry Lu (Founding and Managing Partner) and Dr. Li Jie (Managing Director). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co